Address: 92, Section 2, Chungshan North Road, Taipei City,Taiwan
Tel: (886-2)543-3535
Mackay Memorial Hospital is presently under the jurisdiction of the Presbyterian Church in Taiwan.
The hospital was established in memory of Dr. George Leslie Mackay who followed in the footsteps of his Master by coming to Taiwan with the message of salvation for all men. Even in those early days, Dr. Mackay was concerned with the total person and being able to minister to the physical, emotional and spiritual needs of each patient.
Under the leadership of Dr. Wu and former Chairman of the Board of Directors, Mou Hsiang Wang, the hospital took out a loan to erect a new hospital that would meet international standards. The first stage of this new building was completed on December 26, 1980. This modern 13 story building became the new center for patient care at Mackay. A nine story addition, which houses the medical and administrative offices, was completed on August 6, 1983. Because of the inadequacy of the hospital buildings built in 1912 and 1962 to meet the needs of patients, the board decided to demolish them and begin construction of a 16-story building to expand the present facilities.
●Area: The total land area is 13386 m2, the total area of the buildings is 49,742.36 m2.
●Scale: Medical Administration Building, Patient Care Center (2-story basement, 9-story building and 13-story building)
●Number of Beds: 1091, including 95 ICU beds
●Number of Patients: an average of more than 5000 outpatients and 350 emergency room patients, daily.
Nutrarex Biotech is a Taiwanese private label contract manufacturer of functional supplements, exclusively representing a number of cutting-edge raw materials from Europe, the US, and Japan. Stanley Huang is the…
In an effort to enhance trade and cooperation with other countries in the region and reduce dependency on mainland China, in 2016 Taiwan’s government introduced the New Southbound Policy (NSP).…
Within Taiwan’s evolving medical device sector, many innovative startups are exploring breakthrough ideas which are sparking global interest and attention – iXensor being a chief example. The company’s patented technology…
Mark Yang, CEO of GaleMed, elaborates on the medical device manufacturer’s transition from a privately-owned company to being acquired by private equity firm Nexus Point Capital. Yang goes on to…
United Biomedical, Inc. (UBI) is dedicated to the discovery, development, and commercialization of immunotherapies & vaccines for chronic and infectious diseases and is passionate about delivering science-driven innovation with platform…
James Chiu, GM of Fresenius Kabi Taiwan, discusses the affiliate’s portfolio offering of parenteral and enteral nutrition in Taiwan as well as its move towards biosimilars. In addition, Chiu highlights…
Shuhei Sekiguchi, recently-appointed managing director of Janssen Taiwan, discusses how his vast experience in marketing and sales will help him in this new role, Janssen´s market outlook for Taiwan, its…
The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each…
G-SYN Biomedical Technology is a company dedicated to resolving problems occurring from cell hypoxia. Dieter Chang, the company’s founder introduces the firm, why they decided to focus on hypoxia, their…
Philip Chen, chairman of the Taipei Exchange, discusses the capital market condition, elaborates on the significance of biotech, and shares the competitive advantages of innovation companies listing on TPEx. Chen…
Danny Liao, CEO of Taiwanese diagnostics firm Skyla discusses the reason behind splitting from parent company Lite-On, the thinking behind a move from information technology (IT) into medical diagnostics and…
The Southern Taiwan Science Park (STSP)’s Chen-Kang Su discusses how STSP has played a key role in bringing innovation to Taiwan, how collaborations between academic institutions and industry are helping…
See our Cookie Privacy Policy Here
